Progressive MS publications
Papers and presentations from the Progressive MS program.
All publications and presentations
- Peer-reviewedEvaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis Multiple Sclerosis Journal View source
- PresentationPhase 2 open-label, multicenter study of repeated intrathecal administration of autologous MSC-NTF cells in progressive multiple sclerosis 2019 Annual CMSC Meeting View source
BrainStorm's autologous MSC-NTF cell therapy (NurOwn®, debamestrocel) is investigational and has not been approved by the FDA or any other regulatory authority.